Deadline Alert: Exscientia Investors Encouraged to Act Before June 25 Class Action Deadline

LOS ANGELES, May 30, 2024 – Renowned legal firm Glancy Prongay & Murray LLP ('GPM') is issuing a reminder to shareholders of Exscientia p.l.c. EXAI about the approaching deadline of June 25, 2024, to file a lead plaintiff motion in the lawsuit filed on behalf of Exscientia investors. The class action seeks to represent investors who purchased or otherwise acquired shares of the artificial intelligence-driven pharmaceutical tech company Exscientia, headquartered in Oxford, United Kingdom.

Investor Alert: Upcoming Filing Deadline

Investors who have significant losses are encouraged to contact the firm before the June deadline. Exscientia EXAI, which specializes in the discovery, design, and development of drugs through its AI-powered platform, has become the focal point of this litigation. Shareholders who have been affected by any alleged corporate misdeeds are given the opportunity to potentially recover their financial losses.

Exscientia’s Market Standing

As a leader in the application of artificial intelligence to drug discovery, Exscientia EXAI prides itself on streamlining the drug development process, which traditionally involves significant time and resource investment. The class action underscores the importance of holding companies accountable for their commitments to shareholders and maintaining market integrity.

Investment, Deadline, Lawsuit